Literature DB >> 12707088

Treatment of cutaneous leishmaniasis with photodynamic therapy.

Claes D Enk1, Clemens Fritsch, Flory Jonas, Abedelmajeed Nasereddin, Arieh Ingber, Charles L Jaffe, Thomas Ruzicka.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12707088     DOI： 10.1001/archderm.139.4.432

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN： 0003-987X


× No keyword cloud information.
  17 in total

1.  [Topical treatment of persistent cutaneous leishmaniasis with paromomycin].

Authors:  M J Flaig; J Rupec; T Ruzicka; R A Rupec
Journal:  Hautarzt       Date:  2007-08       Impact factor: 0.751

Review 2.  Exploiting knowledge on pharmacodynamics-pharmacokinetics for accelerated anti-leishmanial drug discovery/development.

Authors:  Shyam Sundar; Neha Agrawal; Bhawana Singh
Journal:  Expert Opin Drug Metab Toxicol       Date:  2019-06-17       Impact factor: 4.481

3.  Photodynamic sensitization of Leishmania amazonensis in both extracellular and intracellular stages with aluminum phthalocyanine chloride for photolysis in vitro.

Authors:  Sujoy Dutta; Debalina Ray; Bala K Kolli; Kwang-Poo Chang
Journal:  Antimicrob Agents Chemother       Date:  2005-11       Impact factor: 5.191

4.  Topical and Intradermal Efficacy of Photodynamic Therapy with Methylene Blue and Light-Emitting Diode in the Treatment of Cutaneous Leishmaniasis Caused by Leishmania braziliensis.

Authors:  Mônica Raquel Sbeghen; Evandra Maria Voltarelli; Tácito Graminha Campois; Elza Kimura; Sandra Mara Alessi Aristides; Luzmarina Hernandes; Wilker Caetano; Noboru Hioka; Maria Valdrinez Campana Lonardoni; Thaís Gomes Verzignassi Silveira
Journal:  J Lasers Med Sci       Date:  2015-06-28

5.  Monitoring the efficacy of antimicrobial photodynamic therapy in a murine model of cutaneous leishmaniasis using L. major expressing GFP.

Authors:  Elena Latorre-Esteves; Oleg E Akilov; Prakash Rai; Stephen M Beverley; Tayyaba Hasan
Journal:  J Biophotonics       Date:  2010-06       Impact factor: 3.207

6.  Development of a novel formulation with hypericin to treat cutaneous leishmaniasis based on photodynamic therapy in in vitro and in vivo studies.

Authors:  Andrés Montoya; Alejandro Daza; Diana Muñoz; Karina Ríos; Viviana Taylor; David Cedeño; Iván D Vélez; Fernando Echeverri; Sara M Robledo
Journal:  Antimicrob Agents Chemother       Date:  2015-07-13       Impact factor: 5.191

Review 7.  [Cutaneous leishmaniasis].

Authors:  C D Enk; K Gardlo; M Hochberg; A Ingber; T Ruzicka
Journal:  Hautarzt       Date:  2003-04-18       Impact factor: 0.751

Review 8.  Light based anti-infectives: ultraviolet C irradiation, photodynamic therapy, blue light, and beyond.

Authors:  Rui Yin; Tianhong Dai; Pinar Avci; Ana Elisa Serafim Jorge; Wanessa C M A de Melo; Daniela Vecchio; Ying-Ying Huang; Asheesh Gupta; Michael R Hamblin
Journal:  Curr Opin Pharmacol       Date:  2013-09-20       Impact factor: 5.547

9.  [Photodynamic therapy of cutaneous leishmaniasis. A promising new therapeutic modality].

Authors:  K Gardlo; S Hanneken; T Ruzicka; N J Neumann
Journal:  Hautarzt       Date:  2004-04       Impact factor: 0.751

Review 10.  [Photodynamic therapy: non-oncologic indications].

Authors:  S Karrer; R-M Szeimies
Journal:  Hautarzt       Date:  2007-07       Impact factor: 0.751
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.